Johnson & Johnson said Wednesday that it has ended a late-stage trial for its experimental HIV vaccine after data showed the shot was ineffective at preventing infections.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.